Richard D. Goold
Technik-/Wissenschafts-/F&E-Leiter bei LYELL IMMUNOPHARMA, INC.
Profil
Richard D.
Goold was the founder of Station X, Inc. (founded in 2010) and Prospect Genomics, Inc. (founded in 2000), where he held the titles of Senior Vice President-Information Sciences and President & Chief Executive Officer, respectively.
Currently, he is the Chief Information Officer at Lyell Immunopharma, Inc. (since 2019).
Previously, he worked as the Chief Genomics Officer at Incyte Corp.
(from 1995 to 2004).
Dr. Goold holds a doctorate degree from the University of Cape Town and undergraduate and graduate degrees from Rhodes University.
Aktive Positionen von Richard D. Goold
| Unternehmen | Position | Beginn |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2019 |
Ehemalige bekannte Positionen von Richard D. Goold
| Unternehmen | Position | Ende |
|---|---|---|
Station X, Inc.
 Station X, Inc. Packaged SoftwareTechnology Services Station X, Inc. develops software products for scientists and clinicians. It provides products to scientists who work with large-scale human genome information in either a research or clinical setting, enabling them to extract maximal biological meaning from complex genomic data. The company was founded by Richard D. Goold, Tod M. Klingler and Andrew R. MacBride in August 2010 and is headquartered in San Francisco, CA. | Gründer | 01.04.2019 |
| INCYTE CORPORATION | Corporate Officer/Principal | 01.04.2004 |
Prospect Genomics, Inc.
 Prospect Genomics, Inc. Packaged SoftwareTechnology Services Prospect Genomics, Inc. developed computational technology solutions for the pharmaceutical field. The company was headquartered in San Diego, CA. | Vorstandsvorsitzender | 01.01.2002 |
Ausbildung von Richard D. Goold
| Rhodes University | Graduate Degree |
| University of Cape Town | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| LYELL IMMUNOPHARMA, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Station X, Inc.
Station X, Inc. Packaged SoftwareTechnology Services Station X, Inc. develops software products for scientists and clinicians. It provides products to scientists who work with large-scale human genome information in either a research or clinical setting, enabling them to extract maximal biological meaning from complex genomic data. The company was founded by Richard D. Goold, Tod M. Klingler and Andrew R. MacBride in August 2010 and is headquartered in San Francisco, CA. | Technology Services |
Prospect Genomics, Inc.
Prospect Genomics, Inc. Packaged SoftwareTechnology Services Prospect Genomics, Inc. developed computational technology solutions for the pharmaceutical field. The company was headquartered in San Diego, CA. | Technology Services |
